| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.1M | +55.0% |
| SG&A Expense | $24.1M | +39.6% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | $78.6M | +86.7% |
| Income Tax | $3K | +0.0% |
| Net Income | $78.6M | +86.7% |
| EPS (Basic) | $0.57 | +35.7% |
| EPS (Diluted) | $0.55 | +37.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $107.9M | +131.3% |
| Current Assets | $331.5M | -26.5% |
| Total Assets | $493.7M | -3.3% |
| Current Liabilities | $19.8M | +373.2% |
| Total Liabilities | $116.8M | -43.6% |
| Stockholders' Equity | $376.9M | +24.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.1M | -18.4% |
| Capital Expenditures | $83.7M | +582.2% |
| Investing Cash Flow | $88.8M | +121.6% |
| Financing Cash Flow | $1.2M | -99.7% |
| Free Cash Flow | -$109.8M | -220.0% |